Stay updated on Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check27 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of February 11, 2025, while removing the previous status of being active but not recruiting and a date of August 5, 2024.SummaryDifference2%
- Check34 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check56 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.